Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

355 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Consensus guidelines for the definition, detection and interpretation of immunogenic cell death.
Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, Gaipl US, Gameiro SR, Garg AD, Golden E, Han J, Harrington KJ, Hemminki A, Hodge JW, Hossain DMS, Illidge T, Karin M, Kaufman HL, Kepp O, Kroemer G, Lasarte JJ, Loi S, Lotze MT, Manic G, Merghoub T, Melcher AA, Mossman KL, Prosper F, Rekdal Ø, Rescigno M, Riganti C, Sistigu A, Smyth MJ, Spisek R, Stagg J, Strauss BE, Tang D, Tatsuno K, van Gool SW, Vandenabeele P, Yamazaki T, Zamarin D, Zitvogel L, Cesano A, Marincola FM. Galluzzi L, et al. Among authors: kepp o. J Immunother Cancer. 2020 Mar;8(1):e000337. doi: 10.1136/jitc-2019-000337. J Immunother Cancer. 2020. PMID: 32209603 Free PMC article. Review.
Molecular characteristics of immunogenic cancer cell death.
Tesniere A, Panaretakis T, Kepp O, Apetoh L, Ghiringhelli F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: kepp o. Cell Death Differ. 2008 Jan;15(1):3-12. doi: 10.1038/sj.cdd.4402269. Epub 2007 Nov 16. Cell Death Differ. 2008. PMID: 18007663 Review.
To die or not to die: that is the autophagic question.
Galluzzi L, Vicencio JM, Kepp O, Tasdemir E, Maiuri MC, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Curr Mol Med. 2008 Mar;8(2):78-91. doi: 10.2174/156652408783769616. Curr Mol Med. 2008. PMID: 18336289 Review.
Hierarchical involvement of Bak, VDAC1 and Bax in cisplatin-induced cell death.
Tajeddine N, Galluzzi L, Kepp O, Hangen E, Morselli E, Senovilla L, Araujo N, Pinna G, Larochette N, Zamzami N, Modjtahedi N, Harel-Bellan A, Kroemer G. Tajeddine N, et al. Among authors: kepp o. Oncogene. 2008 Jul 10;27(30):4221-32. doi: 10.1038/onc.2008.63. Epub 2008 Mar 24. Oncogene. 2008. PMID: 18362892
The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death.
Panaretakis T, Joza N, Modjtahedi N, Tesniere A, Vitale I, Durchschlag M, Fimia GM, Kepp O, Piacentini M, Froehlich KU, van Endert P, Zitvogel L, Madeo F, Kroemer G. Panaretakis T, et al. Among authors: kepp o. Cell Death Differ. 2008 Sep;15(9):1499-509. doi: 10.1038/cdd.2008.67. Epub 2008 May 9. Cell Death Differ. 2008. PMID: 18464797
Immunogenic cancer cell death: a key-lock paradigm.
Tesniere A, Apetoh L, Ghiringhelli F, Joza N, Panaretakis T, Kepp O, Schlemmer F, Zitvogel L, Kroemer G. Tesniere A, et al. Among authors: kepp o. Curr Opin Immunol. 2008 Oct;20(5):504-11. doi: 10.1016/j.coi.2008.05.007. Epub 2008 Jun 23. Curr Opin Immunol. 2008. PMID: 18573340 Review.
Targeting p53 to mitochondria for cancer therapy.
Galluzzi L, Morselli E, Kepp O, Tajeddine N, Kroemer G. Galluzzi L, et al. Among authors: kepp o. Cell Cycle. 2008 Jul 1;7(13):1949-55. doi: 10.4161/cc.7.13.6222. Cell Cycle. 2008. PMID: 18642442 Review.
355 results